Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 605

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach

Open access
Pérez-Cobas, Ana Elena, Gosalbes, María José, Friedrichs, Anette, Knecht, Henrik, Artacho, Alejandro, Eismann, Kathleen, Otto, Wolfgang, Rojo, David, Bargiela, Rafael, von Bergen, Martin, Neulinger, Sven C, Däumer, Carolin, Heinsen, Femke-Anouska, Latorre, Amparo, Barbas, Coral, Seifert, Jana, dos Santos, Vitor Martins, Ott, Stephan J, Ferrer, Manuel, Moya, Andrés·2013·Gut

Abstract

Objective: Antibiotic (AB) usage strongly affects microbial intestinal metabolism and thereby impacts human health. Understanding this process and the underlying mechanisms remains a major research goal. Accordingly, we conducted the first comparative omic investigation of gut microbial communities in faecal samples taken at multiple time points from an individual subjected to β-lactam therapy. Methods: The total (16S rDNA) and active (16S rRNA) microbiota, metagenome, metatranscriptome (mRNAs), metametabolome (high-performance liquid chromatography coupled to electrospray ionisation and quadrupole time-of-flight mass spectrometry) and metaproteome (ultra high performing liquid chromatography coupled to an Orbitrap MS 2 instrument [UPLC-LTQ Orbitrap-MS/MS]) of a patient undergoing AB therapy for 14 days were evaluated. Results: Apparently oscillatory population dynamics were observed, with an early reduction in Gram-negative organisms (day 6) and an overall collapse in diversity and possible further colonisation by ‘presumptive’ naturally resistant bacteria (day 11), followed by the re-growth of Gram-positive species (day 14). During this process, the maximum imbalance in the active microbial fraction occurred later (day 14) than the greatest change in the total microbial fraction, which reached a minimum biodiversity and richness on day 11; additionally, major metabolic changes occurred at day 6. Gut bacteria respond to ABs early by activating systems to avoid the antimicrobial effects of the drugs, while ‘presumptively’ attenuating their overall energetic metabolic status and the capacity to transport and metabolise bile acid, cholesterol, hormones and vitamins; host–microbial interactions significantly improved after treatment cessation. Conclusions: This proof-of-concept study provides an extensive description of gut microbiota responses to follow-up β-lactam therapy. The results demonstrate that ABs targeting specific pathogenic infections and diseases may alter gut microbial ecology and interactions with host metabolism at a much higher level than previously assumed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2012-303184

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 93 references

Cited by

See all 605

Metadata

Authors
Pérez-Cobas, A. E., Gosalbes, M. J., Friedrichs, A., Knecht, H., Artacho, A., Eismann, K., Otto, W., Rojo, D., Bargiela, R., von Bergen, M., Neulinger, S. C., Däumer, C., Heinsen, F.-A., Latorre, A., Barbas, C., Seifert, J., dos Santos, V. M., Ott, S. J., Ferrer, M., & Moya, A.
Venue
Gut
Publisher
BMJ
Published
2012-12-12
Volume
62
Issue
11
Pages
1591-1601
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2133211145
Cited by
605
References
93
FWCI
14.29
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. https://app.cochat.ai/papers/10.1136/gutjnl-2012-303184
The paper
Pérez-Cobas, A. E., Gosalbes, M. J., Friedrichs, A., Knecht, H., Artacho, A., Eismann, K., Otto, W., Rojo, D., Bargiela, R., von Bergen, M., Neulinger, S. C., Däumer, C., Heinsen, F.-A., Latorre, A., Barbas, C., Seifert, J., dos Santos, V. M., Ott, S. J., Ferrer, M., & Moya, A. (2013). Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut. https://doi.org/10.1136/gutjnl-2012-303184

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.